๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

P-577 Treatment of relapsed small cell lung cancer with irinotecan, cisplatin, and mitomycin C (IPM): A phase II study

โœ Scribed by Fennell, Dean A.; Slater, Sarah E.; Steele, Jeremy P.C.; Evans, Marie T.; Constantinidou, Anastasia; Shamash, Jonathan; Wells, Paula; Gower, Nicole H.; Barlow, Claire; Rudd, Robin M.

Book ID
118572272
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
172 KB
Volume
41
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II trial of irinotecan, cisplatin
Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancer
โœ Dean A. Fennell; Jeremy P.C. Steele; Jonathan Shamash; Sarah E. Slater; Michael ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 87 KB ๐Ÿ‘ 1 views

## Abstract There is no standard therapy for relapsed small cell lung cancer (rSCLC). We evaluated the efficacy and toxicity of a new triplet consisting of irinotecan (100 mg/m^2^ Days 1 and 15 q28), cisplatin (40 mg/m^2^ Days 1 and 15 q28) and mitomycin (6 mg/m^2^ d1 q28) administered to a maximum